Women's Health Innovation Summit (WHIS) Announces Innovation Showcase Finalists

12 standout companies selected to present groundbreaking women's health  innovations at WHIS 2026, October 13–15, Encore Boston Harbor 

The Women's Health Innovation Summit (WHIS) today announced the finalists for its  2026 Innovation Showcase, recognizing a select group of companies advancing new  solutions in women's health. The finalists will present live to an audience of investors,  providers, payers, and industry leaders at WHIS, taking place October 13–15 at Encore  Boston Harbor. 

The Innovation Showcase highlights emerging technologies and approaches poised to  shape the future of women's health, spanning everything from diagnostics, medical  devices and therapeutics, to care delivery. Finalists were selected by an expert  Selection Committee for their potential to improve outcomes, expand access, and drive  meaningful change across the sector. 

"This year's applicant pool reflected just how much momentum is building in women's  health innovation. The finalists selected represent some of the most promising thinking  in the space, and we're looking forward to seeing them take the stage," said Poppy  Howard-Wall, Event Director of WHIS. 

This year's Selection Committee was comprised of: 

• Mane Mikayelyan, Associate Partner, DeciBio  

• Parambir Bhangu, Executive Director, External Innovation & Emerging Science, Organon  

• Elizabeth Bailey, Co-Founder & Managing Partner, Foreground Capital  • Anna Valcheva, Founder & Managing Director & CEO, Astra Ventures  • Azin Radsan van Alebeek, Co-Founder & General Partner, Emmeline Ventures  • Jessica Li, Senior Associate, Novo Holdings  

• Anna Mamo, Director, Translational Sciences, UPMC Enterprises  • Kathy Qian, Principal Associate, Medtronic 

Full details on the finalists can be viewed here.

Attendees can expect a live pitch format, with finalists presenting directly to the summit  audience. 

About WHIS 

The Women's Health Innovation Summit convenes leaders across payers, providers,  pharma, employers, and investors to accelerate innovation in women's health.